Table 2.

Gait performance measures

		Patients with							ANOVA
	Healthy subjects	Vestibular disorders	Cerebellar disorders	Functional disorders	Hypokinetic disorders	Vascular disorders	Others	All	F(6;365)	p
Pace domain
Gait velocity [m/s]	1.2 ± 0.2	1.0 ± 0.2	0.9 ± 0.2*	0.8 ± 0.2*	0.7 ± 0.3*	0.9 ± 0.3*	1.0 ± 0.2	1.0 ± 0.3	15.1	< 0.001
Stride length [m]	1.3 ± 0.2	1.1 ± 0.2	1.1 ± 0.3	1.2 ± 0.2	0.8 ± 0.2*	1.1 ± 0.2	1.2 ± 0.2	1.1 ± 0.2	16.9	< 0.001
Stride time [s]	1.1 ± 0.1	1.1 ± 0.1	1.3 ± 0.1*	1.2 ± 0.2	1.3 ± 0.1	1.1 ± 0.1	1.1 ± 0.2	1.2 ± 0.2	4.8	< 0.001
Cycle domain
Swing phase [%]	38 ± 2	37 ± 2	37 ± 2	37 ± 2	33 ± 5 *	37 ± 2	36 ± 3	36 ± 3	9.0	< 0.001
Double support phase [%]	24 ± 4	26 ± 5*	30 ± 9*	26 ± 7	35 ± 12*	26 ± 7*	26 ± 5	27 ± 8	10.1	< 0.001
Support domain
Base of support [m]	0.08 ± 0.03	0.12 ± 0.04*	0.15 ± 0.06*	0.12 ± 0.04*	0.11 ± 0.04*	0.11 ± 0.04*	0.11 ± 0.04*	0.12 ± 0.05	17.4	< 0.001
Base of support CV [%]	24 ± 15	24 ± 13	24 ± 12	21 ± 14*	23 ± 12	20 ± 9*	21 ± 13*	22 ± 13	1.1	n.s
Variability domain
Stride length CV [%]	2.2 ± 1.1	3.8 ± 2.5*	5.6 ± 4.6*	3.1 ± 2.9	7.5 ± 4.2*	3.3 ± 4.2*	3.0 ± 1.3*	3.9 ± 3.0	12.9	< 0.001
Stride time CV [%]	2.3 ± 1.9	3.2 ± 1.8*	5.2 ± 1.2*	3.0 ± 2.1	7.1 ± 1.7*	3.0 ± 2.3	3.2 ± 2.2	3.7 ± 1.7	10.2	< 0.001
Asymmetry domain
Gait asymmetry index [%]	2.5 ± 1.5	4.0 ± 2.6*	6.8 ± 3.7*	4.2 ± 2.4*	10.5 ± 4.7*	4.2 ± 2.6*	4.0 ± 2.1*	4.8 ± 2.2	9.3	< 0.001
Phase synchronization [%]	4.1 ± 1.4	5.9 ± 2.9	9.9 ± 5.3*	5.5 ± 3.3*	12.0 ± 5.6*	5.3 ± 2.5*	5.3 ± 3.2	6.7 ± 5.3	8.0	< 0.001

Outcomes from the in-laboratory gait assessment for the different clinical subgroups and healthy subjects. Spatiotemporal gait parameters are arranged with respect to the gait domains pace, cycle, support, variability, and asymmetry

*Significant difference in the Sheffé post hoc comparison (compared to healthy subjects)

CV coefficient of variation